Véronique Hofman

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

C. Marquette, P. Hofman, V. Hofman, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.

E. Long-Mira, M. Ilié, M. Poudenx, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Usefulness of ancillary methods for diagnosis, prognosis and targeted therapy in thyroid pathology.

A. Bozec, J. Santini, P. Hofman, 2013, Current medicinal chemistry.

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes.

I. Wistuba, P. Van Loo, Y. Xi, 2024, Cancer cell.

Current challenges and practical aspects of molecular pathology for non-small cell lung cancers

B. Mograbi, M. Ilié, Sabina Berezowska, 2023, Virchows Archiv : an international journal of pathology.

Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis

V. Vouret-Craviari, Serena Janho dit Hreich, Véronique Hofman, 2023, bioRxiv.

Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non-Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging.

R. Schiappa, C. Bonnetaud, E. Long-Mira, 2024, The American journal of surgical pathology.

Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors

B. Mograbi, M. Ilié, L. Berland, 2024, Frontiers in immunology.

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi‐Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center

N. Le Stang, N. Girard, A. Nicholson, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.